VEGFA and Insulin resistance: As for novelty in terms of GT, our analyses of bioenergetics and GTT allow us to suggest (with a certain degree of speculation) that especially in HFD conditions HGF/VEGF plasmid gene therapy of hindlimb ischemia can cause adaptive insulin resistance which induces mitochondrial biogenesis in skeletal muscle with consequent enhancing of regeneration energy supply.